Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92205428e0fbc3b39a4bab31a94b5ada http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5958ad9a7c392f9b9f2f968c868f56fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_195631d22dd7927a82eab008108edc83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_260d900e1af26d108a020a76760dd4eb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
filingDate |
2005-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49b5e810e768650b7f11a35a8c023571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_167e05d9499f7066eb7b41b565419872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431bd5c71154a9524727ee993afc776a |
publicationDate |
2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005107375-A3 |
titleOfInvention |
Process for the preparation of olanzapine form-i |
abstract |
The present invention provides a reproducible, novel, commercially feasible process to obtain Olanzapine Form-I of substantial polymorphic purity with minimal number of steps using minimal number of solvents by condensation of 4-Aminomethyl-10H-thieno [2, 3-b] [1, 5] benzodiazepine hydrochloride with N-methyl piperazine followed by isolation of Olanzapine methylene chloride solvate and conversion of the same to Olanzapine Form-I. |
priorityDate |
2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |